Results 21 to 30 of about 5,418,578 (179)

A New Simple and Practical Clinical Classification for Tenosynovial Giant Cell Tumors of the Knee [PDF]

Orthopaedic Surgery, 2022
Objective To propose a simple and practical clinical classification for tenosynovial giant cell tumor (TGCT) of the knee. Methods A retrospective study was conducted to verify the value and significance of this clinical classification.
Kai Zheng, Xiu‐chun Yu, Yong‐cheng Hu, Ming Xu, Jing‐yu Zhang   +4 more
doaj   +2 more sources

Tenosynovial giant‐cell tumor in the knee joint

Arthroscopy, 1995
Abstract We report the case of a tenosynovial giant‐cell tumor causing limitation of extension of the knee. The tumor was treated successfully by arthroscopic removal.
S J, Kim, N H, Choi, S C, Lee
openaire   +4 more sources

Tenosynovial giant cell tumor presenting as a parotid gland mass: Expanding the differential diagnosis of giant cell-rich lesions in salivary glands

Journal of Cytology, 2014
Tenosynovial giant cell tumors (TGCT) are rare benign soft tissue tumors affecting mostly young adults. The most common affected sites include the knee, ankle, elbow, shoulder, and fingers. The temporomandibular joint is occasionally affected. Herein, we
Ling Guo, Shadi Qasem, Simon Bergman, Ziyan T Salih   +3 more
doaj   +2 more sources

Tenosynovial Giant Cell Tumor of the Ankle: A Case Report with an Unusual Location [PDF]

Ahi Evran Medical Journal, 2023
Tenosynovial giant cell tumor (TSDHT) is a slow-growing benign tumor arising from the tendon sheath or bursa. TSDHT of the foot and foot ankle has been reported much less frequently compared to the hand and knee.
Hatice KAPLANOĞLU, Veysel KAPLANOĞLU, Aynur TURAN, Rasime Pelin KAVAK, Tuba AKDAĞ   +4 more
doaj   +2 more sources

Tenosynovial Giant Cell Tumors of the Hand: Analysis of Risk Factors for Surgical Margin and Recurrence [PDF]

Medicina
Background and Objective: Tenosynovial giant cell tumors (TGCTs) are benign but potentially aggressive soft-tissue tumors, most commonly affecting the hand and frequently associated with local recurrence despite surgical treatment.
Tolgahan Cengiz, Şafak Aydın Şimşek, Ercan Bayar, Furkan Erdoğan, Alparslan Yurtbay, Hüseyin Sina Coşkun, Ahmet Pişkin, Nevzat Dabak   +7 more
doaj   +2 more sources

Medical Management of Tenosynovial Giant Cell Tumor

Current Oncology Reports
Abstract Purpose of Review Diffuse tenosynovial giant cell tumor (D-TGCT) is a benign neoplasm with locally aggressive potential of the synovium, bursae, and tendon sheaths. This review summarizes the current treatment landscape for D-TGCT, with a focus on systemic therapies.
Palmerini, Emanuela, Trent, Jonathan C., Hornicek Jr, Francis John   +2 more
openaire   +3 more sources

Exploration of the molecular biological mechanisms and review of postoperative radiotherapy cases in tenosynovial giant cell tumors [PDF]

Frontiers in Oncology
Tendon Sheath Giant Cell Tumor (TGCT) is a benign tumor that primarily grows within joints and bursae. However, it has a high postoperative recurrence rate, ranging from 15% to 45%. Although radiotherapy may reduce this recurrence rate, its applicability
Tianwei Zhang, Bin Zeng, Ke Liu, Qin Zeng, Na Wang, Ling Peng, Hongbo Qiu, Xiaomei Chen, Lin Wang   +8 more
doaj   +2 more sources

Investigating vimseltinib in tenosynovial giant cell tumors

Expert Opinion on Pharmacotherapy
Tenosynovial giant cell tumors (TGCTs) are locally aggressive mesenchymal neoplasms that can cause chronic disability. Surgery is a mainstay of treatment but can carry a high risk of morbidity or can confer limited benefit. As such, effective alternative treatment options are needed, including systemic agents.
Rashmi Chugh, Victoria Wytiaz
exaly   +3 more sources

Hypophosphatemic osteomalacia caused by diffuse tenosynovial giant cell tumor misdiagnosed as spondyloarthritis: a case report [PDF]

Frontiers in Endocrinology
Tumor-induced osteomalacia (TIO) is an acquired hypophosphatemic osteodystrophy caused by increased renal phosphate excretion due to tumors. Tenosynovial giant cell tumor (TGCT) is a benign mesenchymal tumor but rarely causes hypophosphatemia.
Yazhen Su, Yazhen Su, Xingxing Zhao, Ruihong Hou, Ruihong Hou, Dan Ma, Dan Ma, Ke Xu, Ke Xu, Liyun Zhang, Liyun Zhang   +10 more
doaj   +2 more sources

Patient-reported Symptoms of Tenosynovial Giant Cell Tumors. [PDF]

Clin Ther, 2016
Tenosynovial giant cell tumor (TGCT), a rare locally aggressive neoplasm of the synovium of joints and tendon sheaths, is associated with joint destruction, inflammation, pain, and swelling, in part due to colony-stimulating factor 1 receptor-bearing macrophages recruited to the tumor by genetic elevation of colony-stimulating factor 1 activity.
Gelhorn HL, Tong S, McQuarrie K, Vernon C, Hanlon J, Maclaine G, Lenderking W, Ye X, Speck RM, Lackman RD, Bukata SV, Healey JH, Keedy VL, Anthony SP, Wagner AJ, Von Hoff DD, Singh AS, Becerra CR, Hsu HH, Lin PS, Tap WD.   +20 more
europepmc   +4 more sources